Matzim LA Interactions
There are 694 drugs known to interact with Matzim LA (diltiazem), along with 9 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 115 are major, 521 are moderate, and 58 are minor.
- View all 694 medications that may interact with Matzim LA
- View Matzim LA alcohol/food interactions (1)
- View Matzim LA disease interactions (9)
Most frequently checked interactions
View interaction reports for Matzim LA (diltiazem) and the medicines listed below.
- albuterol
- allopurinol
- alprazolam
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- carvedilol
- Crestor (rosuvastatin)
- cyclobenzaprine
- Cymbalta (duloxetine)
- doxycycline
- Eliquis (apixaban)
- furosemide
- gabapentin
- hydrochlorothiazide
- levothyroxine
- lisinopril
- lorazepam
- losartan
- metformin
- montelukast
- nitrofurantoin
- omeprazole
- pantoprazole
- prednisone
- rosuvastatin
- simvastatin
- trazodone
- Vitamin D3 (cholecalciferol)
Matzim LA alcohol/food interactions
There is 1 alcohol/food interaction with Matzim LA (diltiazem).
Matzim LA disease interactions
There are 9 disease interactions with Matzim LA (diltiazem) which include:
- aortic stenosis
- bradyarrhythmia/AV block
- cardiogenic shock/hypotension
- coronary artery disease
- liver disease
- CHF/AMI
- accessory AV tracts
- ventricular tachycardia
- renal dysfunction
More about Matzim LA (diltiazem)
- Matzim LA consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcium channel blocking agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.